Rochester Skin Lymphoma Medical Group

Rochester Skin Lymphoma Medical Group is a U.S.-based specialty center focused on the diagnosis, treatment, and research of cutaneous (skin) lymphomas. The group offers advanced therapies and compassionate care, with a strong emphasis on clinical research and patient-focused innovation. It is led by physicians with extensive academic and research backgrounds in skin lymphomas and related dermatologic diseases. The center is recognized for participating in clinical trials, including confirmatory studies for topical agents like HyBryte™ (synthetic hypericin), and has a laboratory at Rochester General Hospital Research Institute for translational skin cancer research. The group accepts Medicare and Medicaid and is open to new patients.